Publications

  1. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

    Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM, Nussenzweig MC, Hatziioannou T, Bieniasz PD.

    Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.

    PMID: 33112236 Free PMC article.

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

    Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schlüter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Çölkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela ŞN, Rodríguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouénan C; COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort; NIAID-USUHS/TAGC COVID Immunity Group, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, García-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Béziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL.

    Science. 2020 Oct 23;370(6515):eabd4570. doi: 10.1126/science.abd4570. Epub 2020 Sep 24.

    PMID: 32972995 Free PMC article.

  3. Evolution of antibody immunity to SARS-CoV-2.

    Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, Hägglöf T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC.

    Nature. 2021 Mar;591(7851):639-644. doi: 10.1038/s41586-021-03207-w. Epub 2021 Jan 18.

    PMID: 33461210 Free PMC article.

  4. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J; HGID Lab; NIAID-USUHS Immune Response to COVID Group; COVID Clinicians; COVID-STORM Clinicians; Imagine COVID Group; French COVID Cohort Study Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL.

    Science. 2020 Oct 23;370(6515):eabd4585. doi: 10.1126/science.abd4585. Epub 2020 Sep 24.

    PMID: 32972996 Free PMC article.

  5. Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

    Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hägglöf T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West AP Jr, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC.

    Nature. 2020 Aug;584(7821):437-442. doi: 10.1038/s41586-020-2456-9. Epub 2020 Jun 18.

    PMID: 32555388 Free PMC article.

  6. SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

    Chakraborty S, Mallajosyula V, Tato CM, Tan GS, Wang TT.

    Adv Drug Deliv Rev. 2021 May;172:314-338. doi: 10.1016/j.addr.2021.01.014. Epub 2021 Jan 20.

    PMID: 33482248 Free PMC article. Review.

  7. The role of IgG Fc receptors in antibody-dependent enhancement.

    Bournazos S, Gupta A, Ravetch JV.

    Nat Rev Immunol. 2020 Oct;20(10):633-643. doi: 10.1038/s41577-020-00410-0. Epub 2020 Aug 11.

    PMID: 32782358 Free PMC article. Review.

  8. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

    Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, Wang TT, Schwartz RE, Lim JK, Albrecht RA, tenOever BR.

    Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.

    PMID: 32416070 Free PMC article.

  9. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.

    Schneider WM, Luna JM, Hoffmann HH, Sánchez-Rivera FJ, Leal AA, Ashbrook AW, Le Pen J, Ricardo-Lax I, Michailidis E, Peace A, Stenzel AF, Lowe SW, MacDonald MR, Rice CM, Poirier JT.

    Cell. 2021 Jan 7;184(1):120-132.e14. doi: 10.1016/j.cell.2020.12.006. Epub 2020 Dec 9.

    PMID: 33382968 Free PMC article.

  10. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

    Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Caskey M, Robbiani DF, Nussenzweig MC, Rice CM, Hatziioannou T, Bieniasz PD.

    J Exp Med. 2020 Nov 2;217(11):e20201181. doi: 10.1084/jem.20201181.

    PMID: 32692348 Free PMC article.

  11. Enhanced SARS-CoV-2 neutralization by dimeric IgA.

    Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C, Cipolla M, Hoffmann HH, Oliveira TY, Oren DA, Ramos V, Nogueira L, Michailidis E, Robbiani DF, Gazumyan A, Rice CM, Hatziioannou T, Bieniasz PD, Caskey M, Nussenzweig MC.

    Sci Transl Med. 2021 Jan 20;13(577):eabf1555. doi: 10.1126/scitranslmed.abf1555. Epub 2020 Dec 7.

    PMID: 33288661 Free PMC article.

  12. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.

    Barnes CO, West AP Jr, Huey-Tubman KE, Hoffmann MAG, Sharaf NG, Hoffman PR, Koranda N, Gristick HB, Gaebler C, Muecksch F, Lorenzi JCC, Finkin S, Hägglöf T, Hurley A, Millard KG, Weisblum Y, Schmidt F, Hatziioannou T, Bieniasz PD, Caskey M, Robbiani DF, Nussenzweig MC, Bjorkman PJ.

    Cell. 2020 Aug 20;182(4):828-842.e16. doi: 10.1016/j.cell.2020.06.025. Epub 2020 Jun 24.

    PMID: 32645326 Free PMC article.

  13. Signaling by Antibodies: Recent Progress.

    Bournazos S, Wang TT, Dahan R, Maamary J, Ravetch JV.

    Annu Rev Immunol. 2017 Apr 26;35:285-311. doi: 10.1146/annurev-immunol-051116-052433.

    PMID: 28446061 Free PMC article. Review.

  14. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo.

    Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Maison RM, Gazumyan A, Martinez DR, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Bowen RA, Nussenzweig MC, Sheahan TP.

    J Exp Med. 2021 Mar 1;218(3):e20201993. doi: 10.1084/jem.20201993.

    PMID: 33211088 Free PMC article.

  15. Functional diversification of IgGs through Fc glycosylation.

    Wang TT, Ravetch JV.

    J Clin Invest. 2019 Sep 3;129(9):3492-3498. doi: 10.1172/JCI130029.

    PMID: 31478910 Free PMC article. Review.

  16. Proinflammatory IgG Fc structures in patients with severe COVID-19.

    Chakraborty S, Gonzalez J, Edwards K, Mallajosyula V, Buzzanco AS, Sherwood R, Buffone C, Kathale N, Providenza S, Xie MM, Andrews JR, Blish CA, Singh U, Dugan H, Wilson PC, Pham TD, Boyd SD, Nadeau KC, Pinsky BA, Zhang S, Memoli MJ, Taubenberger JK, Morales T, Schapiro JM, Tan GS, Jagannathan P, Wang TT.

    Nat Immunol. 2021 Jan;22(1):67-73. doi: 10.1038/s41590-020-00828-7. Epub 2020 Nov 9.

    PMID: 33169014 Free PMC article.

  17. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.

    Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Lim SA, Zhou XX, Hobman TC, Kortemme T, Wells JA.

    Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28046-28055. doi: 10.1073/pnas.2016093117. Epub 2020 Oct 22.

    PMID: 33093202 Free PMC article.

  18. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.

    Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Jean GH, Stevens BA, Lee JY, Rustagi A, Rogers AJ, Powell AE, Hunter M, Najeeb J, Otrelo-Cardoso AR, Yost KE, Daniel B, Nadeau KC, Chang HY, Satpathy AT, Jardetzky TS, Kim PS, Wang TT, Pinsky BA, Blish CA, Boyd SD.

    Cell Host Microbe. 2020 Oct 7;28(4):516-525.e5. doi: 10.1016/j.chom.2020.09.002. Epub 2020 Sep 3.

    PMID: 32941787 Free PMC article.

  19. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.

    Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, Hunter M, Wang H, Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD, Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Jardetzky TS, Zehnder JL, Wang TT, Narasimhan B, Gombar S, Tibshirani R, Nadeau KC, Kim PS, Pinsky BA, Boyd SD.

    Sci Immunol. 2020 Dec 7;5(54):eabe0240. doi: 10.1126/sciimmunol.abe0240.

    PMID: 33288645 Free PMC article.

  20. Intrinsic Immunity Shapes Viral Resistance of Stem Cells.

    Wu X, Dao Thi VL, Huang Y, Billerbeck E, Saha D, Hoffmann HH, Wang Y, Silva LAV, Sarbanes S, Sun T, Andrus L, Yu Y, Quirk C, Li M, MacDonald MR, Schneider WM, An X, Rosenberg BR, Rice CM.

    Cell. 2018 Jan 25;172(3):423-438.e25. doi: 10.1016/j.cell.2017.11.018. Epub 2017 Dec 14.

    PMID: 29249360 Free PMC article.

  21. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.

    Hoffmann HH, Sánchez-Rivera FJ, Schneider WM, Luna JM, Soto-Feliciano YM, Ashbrook AW, Le Pen J, Leal AA, Ricardo-Lax I, Michailidis E, Hao Y, Stenzel AF, Peace A, Zuber J, Allis CD, Lowe SW, MacDonald MR, Poirier JT, Rice CM.

    Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5. doi: 10.1016/j.chom.2020.12.009. Epub 2020 Dec 16.

    PMID: 33357464 Free PMC article.

  22. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.

    Byrnes JR, Zhou XX, Lui I, Elledge SK, Glasgow JE, Lim SA, Loudermilk RP, Chiu CY, Wang TT, Wilson MR, Leung KK, Wells JA.

    mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.

    PMID: 32938700 Free PMC article.

  23. IgG Fc Glycosylation in Human Immunity.

    Wang TT.

    Curr Top Microbiol Immunol. 2019;423:63-75. doi: 10.1007/82_2019_152.

    PMID: 30805712 Free PMC article. Review.

  24. Human genetics of life-threatening influenza pneumonitis.

    Zhang Q.

    Hum Genet. 2020 Jun;139(6-7):941-948. doi: 10.1007/s00439-019-02108-3. Epub 2020 Feb 5.

    PMID: 32025908 Free PMC article. Review.

  25. Diversification of IgG effector functions.

    Bournazos S, Ravetch JV.

    Int Immunol. 2017 Jul 1;29(7):303-310. doi: 10.1093/intimm/dxx025.

    PMID: 28472280 Free PMC article. Review.

  26. Human genetic basis of fulminant viral hepatitis.

    Jouanguy E.

    Hum Genet. 2020 Jun;139(6-7):877-884. doi: 10.1007/s00439-020-02166-y. Epub 2020 Apr 13.

    PMID: 32285199 Free PMC article. Review.

  27. Human Genetic Determinants of Viral Diseases.

    Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS.

    Annu Rev Genet. 2017 Nov 27;51:241-263. doi: 10.1146/annurev-genet-120116-023425. Epub 2017 Aug 30.

    PMID: 28853921 Free PMC article. Review.

  28. Human inborn errors of immunity to herpes viruses.

    Jouanguy E, Béziat V, Mogensen TH, Casanova JL, Tangye SG, Zhang SY.

    Curr Opin Immunol. 2020 Feb;62:106-122. doi: 10.1016/j.coi.2020.01.004. Epub 2020 Jan 31.

    PMID: 32014647 Free PMC article. Review.

  29. Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

    Wang TT, Bournazos S, Ravetch JV.

    Curr Opin Immunol. 2018 Aug;53:124-129. doi: 10.1016/j.coi.2018.04.026. Epub 2018 May 10.

    PMID: 29753885 Free PMC article. Review.

  30. Persistent Cellular Immunity to SARS-CoV-2 Infection.

    Breton G, Mendoza P, Hagglof T, Oliveira TY, Schaefer-Babajew D, Gaebler C, Turroja M, Hurley A, Caskey M, Nussenzweig MC.

    bioRxiv. 2020 Dec 9:2020.12.08.416636. doi: 10.1101/2020.12.08.416636. Preprint.

    PMID: 33330867 Free PMC article. Updated.

  31. Fcγ Receptor Function and the Design of Vaccination Strategies.

    Bournazos S, Ravetch JV.

    Immunity. 2017 Aug 15;47(2):224-233. doi: 10.1016/j.immuni.2017.07.009.

    PMID: 28813656 Free PMC article. Review.

  32. Immunity after SARS-CoV-2 infections.

    Jagannathan P, Wang TT.

    Nat Immunol. 2021 May;22(5):539-540. doi: 10.1038/s41590-021-00923-3.

    PMID: 33875881 No abstract available.

  33. The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses.

    Thulin NK, Wang TT.

    Vaccines (Basel). 2018 Jun 29;6(3):36. doi: 10.3390/vaccines6030036.

    PMID: 29966222 Free PMC article. Review.

  34. The Role and Function of Fcγ Receptors on Myeloid Cells.

    Bournazos S, Wang TT, Ravetch JV.

    Microbiol Spectr. 2016 Dec;4(6):10.1128/microbiolspec.MCHD-0045-2016. doi: 10.1128/microbiolspec.MCHD-0045-2016.

    PMID: 28087938 Free PMC article. Review.

  35. A dark side to NS1 antibodies?

    Robbiani DF, Růžek D.

    J Exp Med. 2021 Sep 6;218(9):e20211348. doi: 10.1084/jem.20211348. Epub 2021 Jul 28.

    PMID: 34319348

  36. Persistent cellular immunity to SARS-CoV-2 infection.

    Breton G, Mendoza P, Hägglöf T, Oliveira TY, Schaefer-Babajew D, Gaebler C, Turroja M, Hurley A, Caskey M, Nussenzweig MC.

    J Exp Med. 2021 Apr 5;218(4):e20202515. doi: 10.1084/jem.20202515.

    PMID: 33533915 Free PMC article.

  37. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.

    Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Lim SA, Zha S, Yamin R, Kao K, Rosenberg OS, Ravetch JV, Wiita AP, Leung KK, Zhou XX, Hobman TC, Kortemme T, Wells JA.

    bioRxiv. 2020 Aug 4:2020.07.31.231746. doi: 10.1101/2020.07.31.231746. Preprint.

    PMID: 32766586 Free PMC article. Updated.

  38. An aberrant inflammatory response in severe COVID-19.

    Merad M, Subramanian A, Wang TT.

    Cell Host Microbe. 2021 Jul 14;29(7):1043-1047. doi: 10.1016/j.chom.2021.06.018.

    PMID: 34265243 Free PMC article.

  39. Illuminating the Fc dependence of SARS-CoV-2 neutralization.

    González JC, Wang TT.

    Immunity. 2021 Sep 14;54(9):1912-1914. doi: 10.1016/j.immuni.2021.08.024. Epub 2021 Aug 25.

    PMID: 34464594 Free PMC article.

  40. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

    Zhang SY, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova JL.

    Curr Opin Immunol. 2019 Aug;59:88-100. doi: 10.1016/j.coi.2019.03.008. Epub 2019 May 20.

    PMID: 31121434 Free PMC article. Review.

  41. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.

    Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer N, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA.

    medRxiv. 2020 Aug 21:2020.08.17.20176925. doi: 10.1101/2020.08.17.20176925. Preprint.

    PMID: 32839788 Free PMC article. Updated.

  42. Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro.

    Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C, Cipolla M, Hoffman HH, Oliveira TY, Oren DA, Ramos V, Nogueira L, Michailidis E, Robbiani DF, Gazumyan A, Rice CM, Hatziioannou T, Bieniasz PD, Caskey M, Nussenzweig MC.

    bioRxiv. 2020 Sep 9:2020.09.09.288555. doi: 10.1101/2020.09.09.288555. Preprint.

    PMID: 32935095 Free PMC article. Updated.

  43. Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.

    Yamin R, Jones AT, Hoffmann HH, Schäfer A, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S.

    Nature. 2021 Nov;599(7885):465-470. doi: 10.1038/s41586-021-04017-w. Epub 2021 Sep 21.

    PMID: 34547765

  44. Replication and single-cycle delivery of SARS-CoV-2 replicons.

    Ricardo-Lax I, Luna JM, Thao TTN, Le Pen J, Yu Y, Hoffmann HH, Schneider WM, Razooky BS, Fernandez-Martinez J, Schmidt F, Weisblum Y, Trüeb BS, Berenguer Veiga I, Schmied K, Ebert N, Michailidis E, Peace A, Sánchez-Rivera FJ, Lowe SW, Rout MP, Hatziioannou T, Bieniasz PD, Poirier JT, MacDonald MR, Thiel V, Rice CM.

    Science. 2021 Nov 26;374(6571):1099-1106. doi: 10.1126/science.abj8430. Epub 2021 Oct 14.

    PMID: 34648371

  45. Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.

    Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hagglof T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West AP Jr, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC.

    bioRxiv. 2020 May 22:2020.05.13.092619. doi: 10.1101/2020.05.13.092619. Preprint.

    PMID: 32511384 Free PMC article. Updated.

  46. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

    Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Caskey M, Robbiani DF, Nussenzweig MC, Rice CM, Hatziioannou T, Bieniasz PD.

    bioRxiv. 2020 Jun 9:2020.06.08.140871. doi: 10.1101/2020.06.08.140871. Preprint.

    PMID: 32577658 Free PMC article. Updated.

  47. Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants.

    Thulin NK, Brewer RC, Sherwood R, Bournazos S, Edwards KG, Ramadoss NS, Taubenberger JK, Memoli M, Gentles AJ, Jagannathan P, Zhang S, Libraty DH, Wang TT.

    Cell Rep. 2020 May 12;31(6):107642. doi: 10.1016/j.celrep.2020.107642.

    PMID: 32402275 Free PMC article.

  48. Risk of Zika microcephaly correlates with features of maternal antibodies.

    Robbiani DF, Olsen PC, Costa F, Wang Q, Oliveira TY, Nery N Jr, Aromolaran A, do Rosário MS, Sacramento GA, Cruz JS, Khouri R, Wunder EA Jr, Mattos A, de Paula Freitas B, Sarno M, Archanjo G, Daltro D, Carvalho GBS, Pimentel K, de Siqueira IC, de Almeida JRM, Henriques DF, Lima JA, Vasconcelos PFC, Schaefer-Babajew D, Azzopardi SA, Bozzacco L, Gazumyan A, Belfort R Jr, Alcântara AP, Carvalho G, Moreira L, Araujo K, Reis MG, Keesler RI, Coffey LL, Tisoncik-Go J, Gale M Jr, Rajagopal L, Adams Waldorf KM, Dudley DM, Simmons HA, Mejia A, O'Connor DH, Steinbach RJ, Haese N, Smith J, Lewis A, Colgin L, Roberts V, Frias A, Kelleher M, Hirsch A, Streblow DN, Rice CM, MacDonald MR, de Almeida ARP, Van Rompay KKA, Ko AI, Nussenzweig MC.

    J Exp Med. 2019 Oct 7;216(10):2302-2315. doi: 10.1084/jem.20191061. Epub 2019 Aug 14.

    PMID: 31413072 Free PMC article.

  49. Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2.

    Rosado-Olivieri EA, Razooky B, Hoffmann HH, De Santis R, Rice CM, Brivanlou AH.

    bioRxiv. 2021 Jan 6:2021.01.06.425622. doi: 10.1101/2021.01.06.425622. Preprint.

    PMID: 33442697 Free PMC article.

  50. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.

    Manry J, Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen L, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Mégarbane B, Triantafyllia V, Fekkar A, Heath J, Franco J, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte O, Zhang Y, Snow A, Holland S, Biggs C, Moncada-Vélez M, Arias A, Lorenzo L, Boucherit S, Anglicheau D, Planas A, Haerynck F, Duvlis S, Nussbaum R, Ozcelik T, Keles S, Bousfiha A, Bakkouri JE, Ramirez-Santana C, Paul S, Pan-Hammarstrom Q, Hammarstrom L, Dupont A, Kurolap A, Metz C, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros L, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye S, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann N, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes L, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig M, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer A, Kennelly S, Bourke N, Halwani R, Sharif-Askari F, Dorgham K, Sallette J, Mehlal-Sedkaoui S, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh D, Erikstrup C, Condino-Neto A, Prando C, Bondarenko A, Spaan A, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton R, Mane S, Anderson M, Boisson B, Béziat V, Zhang SY, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, deLamballerie X, Burdet C, Bouadma L, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen P, Rodríguez-Gallego C, Piemonti L, Notarangelo L, Su H, Kisand K, Okada S, Puel A, Jouanguy E, Rice C, Tiberghien P, Zhang Q, Casanova JL, Abel L, Cobat A.

    Res Sq. 2022 Jan 14:rs.3.rs-1225906. doi: 10.21203/rs.3.rs-1225906/v1. Preprint.

    PMID: 35043109 Free PMC article.

  51. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.

    Nielsen SCA, Yang F, Hoh RA, Jackson KJL, Roeltgen K, Lee JY, Rustagi A, Rogers AJ, Powell AE, Kim PS, Wang TT, Pinsky B, Blish CA, Boyd SD.

    Res Sq. 2020 May 6:rs.3.rs-27220. doi: 10.21203/rs.3.rs-27220/v1. Preprint.

    PMID: 32702737 Free PMC article. Updated.

  52. Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2.

    Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Stevens B, Lee JY, Rustagi A, Rogers AJ, Powell AE, Najeeb J, Otrelo-Cardoso AR, Yost KE, Daniel B, Chang HY, Satpathy AT, Jardetzky TS, Kim PS, Wang TT, Pinsky BA, Blish CA, Boyd SD.

    bioRxiv. 2020 Jul 9:2020.07.08.194456. doi: 10.1101/2020.07.08.194456. Preprint.

    PMID: 32676593 Free PMC article. Updated.

  53. ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.

    Zamecnik CR, Rajan JV, Yamauchi KA, Mann SA, Loudermilk RP, Sowa GM, Zorn KC, Alvarenga BD, Gaebler C, Caskey M, Stone M, Norris PJ, Gu W, Chiu CY, Ng D, Byrnes JR, Zhou XX, Wells JA, Robbiani DF, Nussenzweig MC, DeRisi JL, Wilson MR.

    Cell Rep Med. 2020 Oct 20;1(7):100123. doi: 10.1016/j.xcrm.2020.100123. Epub 2020 Sep 24.

    PMID: 32995758 Free PMC article.

  54. Modulating IgG effector function by Fc glycan engineering.

    Li T, DiLillo DJ, Bournazos S, Giddens JP, Ravetch JV, Wang LX.

    Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3485-3490. doi: 10.1073/pnas.1702173114. Epub 2017 Mar 13.

    PMID: 28289219 Free PMC article.

  55. Antibody fucosylation predicts disease severity in secondary dengue infection.

    Bournazos S, Vo HTM, Duong V, Auerswald H, Ly S, Sakuntabhai A, Dussart P, Cantaert T, Ravetch JV.

    Science. 2021 Jun 4;372(6546):1102-1105. doi: 10.1126/science.abc7303.

    PMID: 34083490 Free PMC article.

  56. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination.

    Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva J, Shimeliovich I, Dizon J, Daga M, Millard KG, Turroja M, Schmidt F, Zhang F, Tanfous TB, Jankovic M, Oliveria TY, Gazumyan A, Caskey M, Bieniasz PD, Hatziioannou T, Nussenzweig MC.

    Nature. 2021 Dec;600(7889):517-522. doi: 10.1038/s41586-021-04060-7. Epub 2021 Oct 7.

    PMID: 34619745 Free PMC article.

  57. Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo.

    Schäfer A, Muecksch F, Lorenzi JCC, Leist SR, Cipolla M, Bournazos S, Schmidt F, Gazumyan A, Baric RS, Robbiani DF, Hatziioannou T, Ravetch JV, Bieniasz PD, Nussenzweig MC, Sheahan TP.

    bioRxiv. 2020 Sep 15:2020.09.15.298067. doi: 10.1101/2020.09.15.298067. Preprint.

    PMID: 32995782 Free PMC article. Updated.

  58. Severe influenza pneumonitis in children with inherited TLR3 deficiency.

    Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, Dobbs K, Hernandez N, Goudin N, Hasek ML, García Reino EJ, Lafaille FG, Lorenzo L, Luthra P, Kochetkov T, Bigio B, Boucherit S, Rozenberg F, Vedrinne C, Keller MD, Itan Y, García-Sastre A, Celard M, Orange JS, Ciancanelli MJ, Meyts I, Zhang Q, Abel L, Notarangelo LD, Snoeck HW, Casanova JL, Zhang SY.

    J Exp Med. 2019 Sep 2;216(9):2038-2056. doi: 10.1084/jem.20181621. Epub 2019 Jun 19.

    PMID: 31217193 Free PMC article.

  59. Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.

    Rosenberg BR, Freije CA, Imanaka N, Chen ST, Eitson JL, Caron R, Uhl SA, Zeremski M, Talal A, Jacobson IM, Rice CM, Schoggins JW.

    J Infect Dis. 2018 Jan 30;217(4):650-655. doi: 10.1093/infdis/jix593.

    PMID: 29165633 Free PMC article.

  60. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.

    Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer NS, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA.

    Nat Biotechnol. 2021 Aug;39(8):928-935. doi: 10.1038/s41587-021-00878-8. Epub 2021 Mar 25.

    PMID: 33767397 Free PMC article.

  61. Fc-engineered antibody therapeutics with improved efficacy against COVID-19.

    Ravetch J, Yamin R, Jones A, Hoffmann HH, Kao K, Francis R, Sheahan T, Baric R, Rice C, Bournazos S.

    Res Sq. 2021 May 27:rs.3.rs-555612. doi: 10.21203/rs.3.rs-555612/v1. Preprint.

    PMID: 34075373 Free PMC article.

  62. A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.

    Keeffe JR, Van Rompay KKA, Olsen PC, Wang Q, Gazumyan A, Azzopardi SA, Schaefer-Babajew D, Lee YE, Stuart JB, Singapuri A, Watanabe J, Usachenko J, Ardeshir A, Saeed M, Agudelo M, Eisenreich T, Bournazos S, Oliveira TY, Rice CM, Coffey LL, MacDonald MR, Bjorkman PJ, Nussenzweig MC, Robbiani DF.

    Cell Rep. 2018 Nov 6;25(6):1385-1394.e7. doi: 10.1016/j.celrep.2018.10.031.

    PMID: 30403995 Free PMC article.

  63. IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.

    Wang TT, Sewatanon J, Memoli MJ, Wrammert J, Bournazos S, Bhaumik SK, Pinsky BA, Chokephaibulkit K, Onlamoon N, Pattanapanyasat K, Taubenberger JK, Ahmed R, Ravetch JV.

    Science. 2017 Jan 27;355(6323):395-398. doi: 10.1126/science.aai8128.

    PMID: 28126818 Free PMC article.

  64. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality.

    Mast FD, Navare AT, van der Sloot AM, Coulombe-Huntington J, Rout MP, Baliga NS, Kaushansky A, Chait BT, Aderem A, Rice CM, Sali A, Tyers M, Aitchison JD.

    J Cell Biol. 2020 Oct 5;219(10):e202006159. doi: 10.1083/jcb.202006159.

    PMID: 32785687 Free PMC article.

  65. New-onset IgG autoantibodies in hospitalized patients with COVID-19.

    Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro J, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James JA, Kim PS, Meyer NJ, Nadeau KC, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Luning Prak ET, Utz PJ.

    Nat Commun. 2021 Sep 14;12(1):5417. doi: 10.1038/s41467-021-25509-3.

    PMID: 34521836 Free PMC article.

  66. Single-Cell Sorting of HBsAg-Binding Memory B Cells from Human Peripheral Blood Mononuclear Cells and Antibody Cloning.

    Zhou Y, Liu Z, Wang Z, Zhang Q, Mayer CT, Schoofs T, Nussenzweig MC, de Jong YP, Wang Q.

    STAR Protoc. 2020 Oct 16;1(3):100129. doi: 10.1016/j.xpro.2020.100129. eCollection 2020 Dec 18.

    PMID: 33377023 Free PMC article.

  67. MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche.

    Wu N, Sun H, Zhao X, Zhang Y, Tan J, Qi Y, Wang Q, Ng M, Liu Z, He L, Niu X, Chen L, Liu Z, Li HB, Zeng YA, Roulis M, Liu D, Cheng J, Zhou B, Ng LG, Zou D, Ye Y, Flavell RA, Ginhoux F, Su B.

    Nature. 2021 Apr;592(7855):606-610. doi: 10.1038/s41586-021-03283-y. Epub 2021 Mar 3.

    PMID: 33658717

  68. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

    Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, Schaefer-Babajew D, Cipolla M, Gaebler C, Lieberman JA, Oliveira TY, Yang Z, Abernathy ME, Huey-Tubman KE, Hurley A, Turroja M, West KA, Gordon K, Millard KG, Ramos V, Da Silva J, Xu J, Colbert RA, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Gazumyan A, Caskey M, Bjorkman PJ, Casellas R, Hatziioannou T, Bieniasz PD, Nussenzweig MC.

    Nature. 2021 Apr;592(7855):616-622. doi: 10.1038/s41586-021-03324-6. Epub 2021 Feb 10.

    PMID: 33567448 Free PMC article.

  69. Defining human dendritic cell progenitors by multiparametric flow cytometry.

    Breton G, Lee J, Liu K, Nussenzweig MC.

    Nat Protoc. 2015 Sep;10(9):1407-22. doi: 10.1038/nprot.2015.092. Epub 2015 Aug 20.

    PMID: 26292072 Free PMC article.

  70. A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques.

    Van Rompay KKA, Coffey LL, Kapoor T, Gazumyan A, Keesler RI, Jurado A, Peace A, Agudelo M, Watanabe J, Usachenko J, Singapuri A, Immareddy R, Ardeshir A, Stuart JB, Bournazos S, Ravetch JV, Balderes PJ, Lorenz IC, Esswein SR, Keeffe JR, Bjorkman PJ, Wang Q, Rice CM, MacDonald MR, Nussenzweig MC, Robbiani DF.

    Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7981-7989. doi: 10.1073/pnas.2000414117. Epub 2020 Mar 24.

    PMID: 32209664 Free PMC article.

  71. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

    Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, Hoffmann HH, Barnes CO, Cipolla M, Ramos V, Oliveira TY, Cho A, Schmidt F, Da Silva J, Bednarski E, Aguado L, Yee J, Daga M, Turroja M, Millard KG, Jankovic M, Gazumyan A, Zhao Z, Rice CM, Bieniasz PD, Caskey M, Hatziioannou T, Nussenzweig MC.

    Nature. 2021 Jul;595(7867):426-431. doi: 10.1038/s41586-021-03696-9. Epub 2021 Jun 14.

    PMID: 34126625 Free PMC article.

  72. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency.

    Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J, Kula T, Drutman S, Belkaya S, Rattina V, Lorenzo-Diaz L, Boulai A, Rose Y, Kitabayashi N, Rodero MP, Dumaine C, Blanche S, Lebras MN, Leung MC, Mathew LS, Boisson B, Zhang SY, Boisson-Dupuis S, Giliani S, Chaussabel D, Notarangelo LD, Elledge SJ, Ciancanelli MJ, Abel L, Zhang Q, Marr N, Crow YJ, Su HC, Casanova JL.

    J Exp Med. 2018 Oct 1;215(10):2567-2585. doi: 10.1084/jem.20180628. Epub 2018 Aug 24.

    PMID: 30143481 Free PMC article.

  73. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies.

    Barnes CO, West AP Jr, Huey-Tubman KE, Hoffmann MAG, Sharaf NG, Hoffman PR, Koranda N, Gristick HB, Gaebler C, Muecksch F, Cetrulo Lorenzi JC, Finkin S, Hagglof T, Hurley A, Millard KG, Weisblum Y, Schmidt F, Hatziioannou T, Bieniasz PD, Caskey M, Robbiani DF, Nussenzweig MC, Bjorkman PJ.

    bioRxiv. 2020 May 29:2020.05.28.121533. doi: 10.1101/2020.05.28.121533. Preprint.

    PMID: 32577645 Free PMC article. Updated.

  74. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

    Wang Q, Michailidis E, Yu Y, Wang Z, Hurley AM, Oren DA, Mayer CT, Gazumyan A, Liu Z, Zhou Y, Schoofs T, Yao KH, Nieke JP, Wu J, Jiang Q, Zou C, Kabbani M, Quirk C, Oliveira T, Chhosphel K, Zhang Q, Schneider WM, Jahan C, Ying T, Horowitz J, Caskey M, Jankovic M, Robbiani DF, Wen Y, de Jong YP, Rice CM, Nussenzweig MC.

    Cell Host Microbe. 2020 Aug 12;28(2):335-349.e6. doi: 10.1016/j.chom.2020.05.010. Epub 2020 Jun 5.

    PMID: 32504577 Free PMC article.

  75. Clonal analysis of human dendritic cell progenitor using a stromal cell culture.

    Lee J, Breton G, Aljoufi A, Zhou YJ, Puhr S, Nussenzweig MC, Liu K.

    J Immunol Methods. 2015 Oct;425:21-26. doi: 10.1016/j.jim.2015.06.004. Epub 2015 Jun 6.

    PMID: 26056939 Free PMC article.

  76. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.

    Agudelo M, Palus M, Keeffe JR, Bianchini F, Svoboda P, Salát J, Peace A, Gazumyan A, Cipolla M, Kapoor T, Guidetti F, Yao KH, Elsterová J, Teislerová D, Chrdle A, Hönig V, Oliveira T, West AP, Lee YE, Rice CM, MacDonald MR, Bjorkman PJ, Růžek D, Robbiani DF, Nussenzweig MC.

    J Exp Med. 2021 May 3;218(5):e20210236. doi: 10.1084/jem.20210236.

    PMID: 33831141 Free PMC article.

  77. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.

    Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S, Wang Z, Poston D, Muecksch F, Hatziioannou T, Bieniasz PD, Robbiani DF, Nussenzweig MC, Bjorkman PJ, Bloom JD.

    Nat Commun. 2021 Jul 7;12(1):4196. doi: 10.1038/s41467-021-24435-8.

    PMID: 34234131 Free PMC article.

  78. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.

    Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Lorenzi JCC, Flyak AI, DeLaitsch AT, Huey-Tubman KE, Hou S, Schiffer CA, Gaebler C, Wang Z, Da Silva J, Poston D, Finkin S, Cho A, Cipolla M, Oliveira TY, Millard KG, Ramos V, Gazumyan A, Rutkowska M, Caskey M, Nussenzweig MC, Bjorkman PJ, Hatziioannou T, Bieniasz PD.

    bioRxiv. 2021 Mar 8:2021.03.07.434227. doi: 10.1101/2021.03.07.434227. Preprint.

    PMID: 33758864 Free PMC article. Updated.

  79. Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.

    Maamary J, Wang TT, Tan GS, Palese P, Ravetch JV.

    Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10172-10177. doi: 10.1073/pnas.1707950114. Epub 2017 Sep 5.

    PMID: 28874545 Free PMC article.

  80. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

    Caskey M, Klein F, Lorenzi JC, Seaman MS, West AP Jr, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF, Horwitz JA, Shimeliovich I, Ben-Avraham S, Witmer-Pack M, Platten M, Lehmann C, Burke LA, Hawthorne T, Gorelick RJ, Walker BD, Keler T, Gulick RM, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC.

    Nature. 2015 Jun 25;522(7557):487-91. doi: 10.1038/nature14411. Epub 2015 Apr 8.

    PMID: 25855300 Free PMC article. Clinical Trial.

  81. Circulating precursors of human CD1c+ and CD141+ dendritic cells.

    Breton G, Lee J, Zhou YJ, Schreiber JJ, Keler T, Puhr S, Anandasabapathy N, Schlesinger S, Caskey M, Liu K, Nussenzweig MC.

    J Exp Med. 2015 Mar 9;212(3):401-13. doi: 10.1084/jem.20141441. Epub 2015 Feb 16.

    PMID: 25687281 Free PMC article.

  82. Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

    Robbiani DF, Bozzacco L, Keeffe JR, Khouri R, Olsen PC, Gazumyan A, Schaefer-Babajew D, Avila-Rios S, Nogueira L, Patel R, Azzopardi SA, Uhl LFK, Saeed M, Sevilla-Reyes EE, Agudelo M, Yao KH, Golijanin J, Gristick HB, Lee YE, Hurley A, Caskey M, Pai J, Oliveira T, Wunder EA Jr, Sacramento G, Nery N Jr, Orge C, Costa F, Reis MG, Thomas NM, Eisenreich T, Weinberger DM, de Almeida ARP, West AP Jr, Rice CM, Bjorkman PJ, Reyes-Teran G, Ko AI, MacDonald MR, Nussenzweig MC.

    Cell. 2017 May 4;169(4):597-609.e11. doi: 10.1016/j.cell.2017.04.024.

    PMID: 28475892 Free PMC article.

  83. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.

    Muecksch F, Weisblum Y, Barnes CO, Schmidt F, Schaefer-Babajew D, Wang Z, C Lorenzi JC, Flyak AI, DeLaitsch AT, Huey-Tubman KE, Hou S, Schiffer CA, Gaebler C, Da Silva J, Poston D, Finkin S, Cho A, Cipolla M, Oliveira TY, Millard KG, Ramos V, Gazumyan A, Rutkowska M, Caskey M, Nussenzweig MC, Bjorkman PJ, Hatziioannou T, Bieniasz PD.

    Immunity. 2021 Aug 10;54(8):1853-1868.e7. doi: 10.1016/j.immuni.2021.07.008. Epub 2021 Jul 30.

    PMID: 34331873 Free PMC article.

  84. Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.

    Wang TT, Maamary J, Tan GS, Bournazos S, Davis CW, Krammer F, Schlesinger SJ, Palese P, Ahmed R, Ravetch JV.

    Cell. 2015 Jul 2;162(1):160-9. doi: 10.1016/j.cell.2015.06.026.

    PMID: 26140596 Free PMC article.

  85. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow.

    Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S, Cameron MJ, Sékaly RP, Nussenzweig MC, Liu K.

    J Exp Med. 2015 Mar 9;212(3):385-99. doi: 10.1084/jem.20141442. Epub 2015 Feb 16.

    PMID: 25687283 Free PMC article.

  86. Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.

    Rosenberg BR, Depla M, Freije CA, Gaucher D, Mazouz S, Boisvert M, Bédard N, Bruneau J, Rice CM, Shoukry NH.

    PLoS Pathog. 2018 Sep 17;14(9):e1007290. doi: 10.1371/journal.ppat.1007290. eCollection 2018 Sep.

    PMID: 30222771 Free PMC article.

  87. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

    Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, Shirkani A, Changi-Ashtiani M, Rokni-Zadeh H, Sayar EH, Reisli I, Lefevre-Utile A, Zijlmans D, Jurado A, Pholien R, Drutman S, Belkaya S, Cobat A, Boudewijns R, Jochmans D, Neyts J, Seeleuthner Y, Lorenzo-Diaz L, Enemchukwu C, Tietjen I, Hoffmann HH, Momenilandi M, Pöyhönen L, Siqueira MM, de Lima SMB, de Souza Matos DC, Homma A, Maia MLS, da Costa Barros TA, de Oliveira PMN, Mesquita EC, Gijsbers R, Zhang SY, Seligman SJ, Abel L, Hertzog P, Marr N, Martins RM, Meyts I, Zhang Q, MacDonald MR, Rice CM, Casanova JL, Jouanguy E, Bossuyt X.

    J Exp Med. 2019 Sep 2;216(9):2057-2070. doi: 10.1084/jem.20182295. Epub 2019 Jul 3.

    PMID: 31270247 Free PMC article.

  88. TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability.

    Racine-Brzostek SE, Karbaschi M, Gaebler C, Klasse PJ, Yee J, Caskey M, Yang HS, Hao Y, Sukhu A, Rand S, Chadburn A, Shi Y, Zuk R, Nussenzweig MC, Cushing MM, Zhao Z.

    Clin Chem. 2021 Sep 1;67(9):1249-1258. doi: 10.1093/clinchem/hvab069.

    PMID: 33914041 Free PMC article.

  89. Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.

    Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S, Wang Z, Poston D, Muecksch F, Hatziioannou T, Bieniasz PD, Robbiani DF, Nussenzweig MC, Bjorkman PJ, Bloom JD.

    bioRxiv. 2021 Mar 18:2021.03.17.435863. doi: 10.1101/2021.03.17.435863. Preprint.

    PMID: 33758856 Free PMC article. Updated.

  90. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.

    Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, El Bakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, van de Beek D, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau YL, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Venet F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino-Neto A, Prando C, Bonradenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S; HGID Lab; COVID Clinicians; COVID-STORM Clinicians; NIAID Immune Response to COVID Group; NH-COVAIR Study Group; Danish CHGE; Danish Blood Donor Study; St. James's Hospital; SARS CoV2 Interest group; French COVID Cohort Study Group; Imagine COVID-Group; Milieu Intérieur Consortium; CoV-Contact Cohort; Amsterdam UMC Covid-19; Biobank Investigators; COVID Human Genetic Effort; CONSTANCES cohort; 3C-Dijon Study; Cerba Health-Care; Etablissement du Sang study group, Anderson MS, Boisson B, Béziat V, Zhang SY, Vandreakos E, Hermine O, Pujol A, Peterson P, Mogensen TH, Rowen L, Mond J, Debette S, de Lamballerie X, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova JL.

    Sci Immunol. 2021 Aug 19;6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340.

    PMID: 34413139

  91. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers.

    Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, Pring J, Pack M, Buckley N, Matei I, Lyden D, Green J, Hawthorne T, Marsh HC, Yellin M, Davis T, Keler T, Schlesinger SJ.

    Bone Marrow Transplant. 2015 Jul;50(7):924-30. doi: 10.1038/bmt.2015.74. Epub 2015 Apr 27.

    PMID: 25915810 Free PMC article. Clinical Trial.

  92. Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs.

    Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC.

    J Exp Med. 2016 Dec 12;213(13):2861-2870. doi: 10.1084/jem.20161135. Epub 2016 Nov 18.

    PMID: 27864467 Free PMC article.

 

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Ga